A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- Scientists Discover Potential Blood Test for Asthma Diagnosis and Severity.
- Local News Rutgers-Camden teams up with South Jersey charter school to ease nursing shortage.
- NJACTS Community Engagement Core COVID-19 Resources
- How to Prepare for Respiratory Illness Season: Get Vaccinated.
- Vision Therapy Reverses Concussion-Related Double and Blurred Vision, NJIT-Led Study Finds.
Categories
- Community (2,360)
- Covid (992)
- CTO Events (6)
- News (2,997)
- Pilots (21)